Genetic testing for lymphedema-distichiasis syndrome
We studied the scientific literature and disease guidelines to summarize the clinical utility of genetic testing for lymphedema distichiasis (LD) syndrome. LD is inherited in an autosomal dominant manner, and has unknown prevalence. It is caused by variations in the FOXC2 gene. Clinical diagnosis in...
Main Authors: | Rakhmanov Yeltay, Maltese Paolo Enrico, Paolacci Stefano, Marinelli Carla, Bertelli Matteo |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2018-09-01
|
Series: | The EuroBiotech Journal |
Subjects: | |
Online Access: | https://doi.org/10.2478/ebtj-2018-0026 |
Similar Items
-
Imbalance between Expression of FOXC2 and Its lncRNA in Lymphedema-Distichiasis Caused by Frameshift Mutations
by: Sara Missaglia, et al.
Published: (2021-04-01) -
<i>FOXC2</i> Disease Mutations Identified in Lymphedema Distichiasis Patients Impair Transcriptional Activity and Cell Proliferation
by: Daniela Tavian, et al.
Published: (2020-07-01) -
A novel mutation in the FOXC2 gene: a heterozygous insertion of adenosine (c.867insA) in a family with lymphoedema of lower limbs without distichiasis
by: Planinsek Rucigaj Tanja, et al.
Published: (2017-07-01) -
Genetic testing for lymphedema in RASopathies
by: Paolacci Stefano, et al.
Published: (2018-09-01) -
Genetic testing for lymphatic malformations with or without primary lymphedema
by: Paolacci Stefano, et al.
Published: (2018-09-01)